Dr. Barry Dworkin

A new treatment for pancreatic cancer has been developed that on average increases survival from from six months to 12 but Canadians don’t have access to it. Here’s why.

Medical Mythbusting Commentary for July 15, 2026

Source:
A new cancer treatment is hailed as a breakthrough, but Canadians don’t have access to it. Here’s why.

Related posts:

  1. New medication for Hodgkin's patients who have failed to respond to all other treatments may soon be approved
  2. New advances in advanced melanoma treatment look promising
  3. New medication for the treatment of advanced pancreatic cancer increases median overall survival from 6.7 to 13.2 months.
  4. Why we need to be careful when looking at an observational study that suggests a relationship between sugary sodas and pancreatic cancer risk